Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Germana Castelli, Elvira Pelosi & Ugo Testa. (2018) Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy. OncoTargets and Therapy 11, pages 131-155.
Read now
Read now
Manel Esteller. (2017) Epigenetic drugs: More than meets the eye. Epigenetics 12:5, pages 307-307.
Read now
Read now
Articles from other publishers (38)
Marta Gómez de Cedrón, Rocío Moreno Palomares & Ana Ramírez de Molina. (2023) Metabolo-epigenetic interplay provides targeted nutritional interventions in chronic diseases and ageing. Frontiers in Oncology 13.
Crossref
Crossref
Nando Dulal Das, Hideaki Niwa & Takashi Umehara. (2023) Chemical Inhibitors Targeting the Histone Lysine Demethylase Families with Potential for Drug Discovery. Epigenomes 7:1, pages 7.
Crossref
Crossref
Yihui SongShu WangBin Yu. (2022) Structural and Functional Landscape of FAD-Dependent Histone Lysine Demethylases for New Drug Discovery. Journal of Medicinal Chemistry 66:1, pages 71-94.
Crossref
Crossref
Gilda Padalino, Cassandra A. Celatka, Hugh Y. Rienhoff Jr.Jay H. Kalin, Philip A. Cole, Damien Lassalle, Josephine Forde-Thomas, Iain W. Chalmers, Andrea Brancale, Christoph Grunau & Karl F. Hoffmann. (2023) Chemical modulation of Schistosoma mansoni lysine specific demethylase 1 (SmLSD1) induces wide-scale biological and epigenomic changes. Wellcome Open Research 8, pages 146.
Crossref
Crossref
Amit M. Pant, Christopher J. Pelham & Gopal P. Jadhav. 2023. Epigenetics in Organ Specific Disorders. Epigenetics in Organ Specific Disorders
615
630
.
Xiaoyu Gu, Xue Qiao, Simiao Yu, Xiaorui Song, Lingling Wang & Linsheng Song. (2022) Histone lysine-specific demethylase 1 regulates the proliferation of hemocytes in the oyster Crassostrea gigas. Frontiers in Immunology 13.
Crossref
Crossref
Hideaki Niwa, Chiduru Watanabe, Shin Sato, Toshiyuki Harada, Hisami Watanabe, Ryo Tabusa, Shunsuke Fukasawa, Ayane Shiobara, Tomoko Hashimoto, Osamu Ohno, Kana Nakamura, Keiko Tsuganezawa, Akiko Tanaka, Mikako Shirouzu, Teruki Honma, Kenji Matsuno & Takashi Umehara. (2022)
Structure–Activity Relationship and
In Silico
Evaluation of
cis
- and
trans
-PCPA-Derived Inhibitors of LSD1 and LSD2
. ACS Medicinal Chemistry Letters 13:9, pages 1485-1492.
Crossref
Crossref
Mengshi Liu, Jiacan Jiang, Yapeng Han, Mengying Shi, Xianli Li, Yingxiang Wang, Zhicheng Dong & Cunyi Yang. (2022) Functional Characterization of the Lysine-Specific Histone Demethylases Family in Soybean. Plants 11:11, pages 1398.
Crossref
Crossref
Yasuko Koda, Shin Sato, Hirofumi Yamamoto, Hideaki Niwa, Hisami Watanabe, Chiduru Watanabe, Tomohiro Sato, Kana Nakamura, Akiko Tanaka, Mikako Shirouzu, Teruki Honma, Takehiro Fukami, Hiroo Koyama & Takashi Umehara. (2022) Design and Synthesis of Tranylcypromine-Derived LSD1 Inhibitors with Improved hERG and Microsomal Stability Profiles. ACS Medicinal Chemistry Letters 13:5, pages 848-854.
Crossref
Crossref
Banafshe Abadi, Yasamin Shahsavani, Mahsa Faramarzpour, Nima Rezaei & Hamid‐Reza Rahimi. (2021) Antidepressants with anti‐tumor potential in treating glioblastoma: A narrative review. Fundamental & Clinical Pharmacology 36:1, pages 35-48.
Crossref
Crossref
Ritu Ojha, I-Chung Chen, Chien-Ming Hsieh, Kunal Nepali, Row-Wen Lai, Kai-Cheng Hsu, Tony Eight Lin, Shiow-Lin Pan, Mei-Chuan Chen & Jing-Ping Liou. (2021) Installation of Pargyline, a LSD1 Inhibitor, in the HDAC Inhibitory Template Culminated in the Identification of a Tractable Antiprostate Cancer Agent. Journal of Medicinal Chemistry 64:24, pages 17824-17845.
Crossref
Crossref
Natalia Sacilotto, Paola Dessanti, Michele M. P. Lufino, Alberto Ortega, Alejandra Rodríguez-Gimeno, Jordi Salas, Tamara Maes, Carlos Buesa, Cristina Mascaró & Robert Soliva. (2021)
Comprehensive
in Vitro
Characterization of the LSD1 Small Molecule Inhibitor Class in Oncology
. ACS Pharmacology & Translational Science 4:6, pages 1818-1834.
Crossref
Crossref
Ying-Chao Duan, Lin-Feng Jin, Hong-Mei Ren, Shao-Jie Zhang, Yue-Jiao Liu, Yong-Tao Xu, Zi-Hao He, Yu Song, Hang Yuan, Shu-Hui Chen & Yuan-Yuan Guan. (2021) Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer. European Journal of Medicinal Chemistry 220, pages 113453.
Crossref
Crossref
Yi Zhang, Deqin Rong, Bingbing Li & Yuanxiang Wang. (2021) Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors. Journal of Medicinal Chemistry 64:12, pages 7900-7925.
Crossref
Crossref
Rahman Abdizadeh, Esfandiar Heidarian, Farzin Hadizadeh & Tooba Abdizadeh. (2021) QSAR Modeling, Molecular Docking and Molecular Dynamics Simulations Studies of Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Anticancer Agents. Anti-Cancer Agents in Medicinal Chemistry 21:8, pages 987-1018.
Crossref
Crossref
Hiroki Kitagawa, Masaki Kikuchi, Shin Sato, Hisami Watanabe, Naoki Umezawa, Maiko Kato, Yosuke Hisamatsu, Takashi Umehara & Tsunehiko Higuchi. (2021) Structure-Based Identification of Potent Lysine-Specific Demethylase 1 Inhibitor Peptides and Temporary Cyclization to Enhance Proteolytic Stability and Cell Growth-Inhibitory Activity. Journal of Medicinal Chemistry 64:7, pages 3707-3719.
Crossref
Crossref
Xing-Jie Dai, Ying Liu, Lei-Peng Xue, Xiao-Peng Xiong, Ying Zhou, Yi-Chao Zheng & Hong-Min Liu. (2021) Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1. Journal of Medicinal Chemistry 64:5, pages 2466-2488.
Crossref
Crossref
Xing-Jie Dai, Ying Liu, Xiao-Peng Xiong, Lei-Peng Xue, Yi-Chao Zheng & Hong-Min Liu. (2020) Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective. Journal of Medicinal Chemistry 63:23, pages 14197-14215.
Crossref
Crossref
Sarder Arifuzzaman, Mst Reshma Khatun & Rabeya Khatun. (2020) Emerging of lysine demethylases (KDMs): From pathophysiological insights to novel therapeutic opportunities. Biomedicine & Pharmacotherapy 129, pages 110392.
Crossref
Crossref
Liying Ma, Haojie Wang, Yinghua You, Chaoya Ma, Yuejiao Liu, Feifei Yang, Yichao Zheng & Hongmin Liu. (2020) Exploration of 5-cyano-6-phenylpyrimidin derivatives containing an 1,2,3-triazole moiety as potent FAD-based LSD1 inhibitors. Acta Pharmaceutica Sinica B 10:9, pages 1658-1668.
Crossref
Crossref
Feiying Gu, Yuxin Lin, Zhun Wang, Xiaoxin Wu, Zhenyue Ye, Yuezhen Wang & Huiyin Lan. (2020) Biological roles of LSD1 beyond its demethylase activity. Cellular and Molecular Life Sciences 77:17, pages 3341-3350.
Crossref
Crossref
Eleni Pitsillou, Julia Liang, Andrew Hung & Tom C. Karagiannis. (2020) Chromatin modification by olive phenolics: In silico molecular docking studies utilising the phenolic groups categorised in the OliveNet™ database against lysine specific demethylase enzymes. Journal of Molecular Graphics and Modelling 97, pages 107575.
Crossref
Crossref
Hideaki Niwa, Shin Sato, Noriko Handa, Toru Sengoku, Takashi Umehara & Shigeyuki Yokoyama. (2020)
Development and Structural Evaluation of
N
‐Alkylated
trans
‐2‐Phenylcyclopropylamine‐Based LSD1 Inhibitors
. ChemMedChem 15:9, pages 787-793.
Crossref
Crossref
Margarita A. Tararina & Karen N. Allen. (2020) Bioinformatic Analysis of the Flavin-Dependent Amine Oxidase Superfamily: Adaptations for Substrate Specificity and Catalytic Diversity. Journal of Molecular Biology 432:10, pages 3269-3288.
Crossref
Crossref
Ryuta Takase, Shinjiro Hino, Katsuya Nagaoka, Kotaro Anan, Kensaku Kohrogi, Hirotaka Araki, Yuko Hino, Akihisa Sakamoto, Thomas B. Nicholson, Taiping Chen & Mitsuyoshi Nakao. (2019) Lysine‐specific demethylase‐2 is distinctively involved in brown and beige adipogenic differentiation. The FASEB Journal 33:4, pages 5300-5311.
Crossref
Crossref
Frida S. Herrera-Vázquez, Francisco Hernández-Luis & José L. Medina Franco. (2019) Quinazolines as inhibitors of chromatin-associated proteins in histones. Medicinal Chemistry Research 28:4, pages 395-416.
Crossref
Crossref
Shiori Saito, Jiro Kikuchi, Daisuke Koyama, Shin Sato, Hiroo Koyama, Naoki Osada, Yoshiaki Kuroda, Koshi Akahane, Takeshi Inukai, Takashi Umehara & Yusuke Furukawa. (2019) Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 Inhibitor. Clinical Cancer Research 25:5, pages 1601-1611.
Crossref
Crossref
Yudai Izumi. 2019. The DNA, RNA, and Histone Methylomes. The DNA, RNA, and Histone Methylomes
479
494
.
Yosuke Ota & Takayoshi Suzuki. (2018) Drug Design Concepts for LSD1‐Selective Inhibitors. The Chemical Record 18:12, pages 1782-1791.
Crossref
Crossref
Rona R. Ramsay & Alen Albreht. (2018) Kinetics, mechanism, and inhibition of monoamine oxidase. Journal of Neural Transmission 125:11, pages 1659-1683.
Crossref
Crossref
Iris F. Macheleidt, Priya S. Dalvi, So‐Young Lim, Sonja Meemboor, Lydia Meder, Olivia Käsgen, Marion Müller, Karolin Kleemann, Lingyu Wang, Peter Nürnberg, Vanessa Rüsseler, Stephan C. Schäfer, Esther Mahabir, Reinhard Büttner & Margarete Odenthal. (2018)
Preclinical studies reveal that
LSD
1 inhibition results in tumor growth arrest in lung adenocarcinoma independently of driver mutations
. Molecular Oncology 12:11, pages 1965-1979.
Crossref
Crossref
Naoki Umezawa, Kasumi Tsuji, Shin Sato, Masaki Kikuchi, Hisami Watanabe, Yuhei Horai, Masashi Yamaguchi, Yosuke Hisamatsu, Takashi Umehara & Tsunehiko Higuchi. (2018) Inhibition of FAD-dependent lysine-specific demethylases by chiral polyamine analogues. RSC Advances 8:64, pages 36895-36902.
Crossref
Crossref
Daniela Magliulo, Rosa Bernardi & Samantha Messina. (2018) Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia. Frontiers in Oncology 8.
Crossref
Crossref
Hideaki Niwa, Shin Sato, Tomoko Hashimoto, Kenji Matsuno & Takashi Umehara. (2018) Crystal Structure of LSD1 in Complex with 4-[5-(Piperidin-4-ylmethoxy)-2-(p-tolyl)pyridin-3-yl]benzonitrile. Molecules 23:7, pages 1538.
Crossref
Crossref
Kotaro Anan, Shinjiro Hino, Noriaki Shimizu, Akihisa Sakamoto, Katsuya Nagaoka, Ryuta Takase, Kensaku Kohrogi, Hirotaka Araki, Yuko Hino, Shingo Usuki, Shinya Oki, Hirotoshi Tanaka, Kimitoshi Nakamura, Fumio Endo & Mitsuyoshi Nakao. (2018) LSD1 mediates metabolic reprogramming by glucocorticoids during myogenic differentiation. Nucleic Acids Research 46:11, pages 5441-5454.
Crossref
Crossref
A. Ganesan. (2018) Epigenetic drug discovery: a success story for cofactor interference. Philosophical Transactions of the Royal Society B: Biological Sciences 373:1748, pages 20170069.
Crossref
Crossref
Naoki Osada, Jiro Kikuchi, Takashi Umehara, Shin Sato, Masashi Urabe, Tomoyuki Abe, Nakanobu Hayashi, Masahiko Sugitani, Yutaka Hanazono & Yusuke Furukawa. (2018) Lysine-specific demethylase 1 inhibitors prevent teratoma development from human induced pluripotent stem cells. Oncotarget 9:5, pages 6450-6462.
Crossref
Crossref
Yuichi Amano, Masaki Kikuchi, Shin Sato, Shigeyuki Yokoyama, Takashi Umehara, Naoki Umezawa & Tsunehiko Higuchi. (2017) Development and crystallographic evaluation of histone H3 peptide with N-terminal serine substitution as a potent inhibitor of lysine-specific demethylase 1. Bioorganic & Medicinal Chemistry 25:9, pages 2617-2624.
Crossref
Crossref